Cited by 94Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and ResearchDiabetes Treatment and Management

Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically ill patients in a COVID-19 medical ICU: Proof of concept

Open access
Davis, Georgia M., Faulds, Eileen, Walker, Tara, Vigliotti, Debbie, Rabinovich, Marina, Hester, Joi, Peng, Limin, McLean, Barbara +10 more·2021·Diabetes Care

Published version of a preprint

Abstract

OBJECTIVE: The use of remote real-time continuous glucose monitoring (CGM) in the hospital has rapidly emerged to preserve personal protective equipment and reduce potential exposures during coronavirus disease 2019 (COVID-19). RESEARCH DESIGN AND METHODS: We linked a hybrid CGM and point-of-care (POC) glucose testing protocol to a computerized decision support system for continuous insulin infusion and integrated a validation system for sensor glucose values into the electronic health record. We report our proof-of-concept experience in a COVID-19 intensive care unit. RESULTS: All nine patients required mechanical ventilation and corticosteroids. During the protocol, 75.7% of sensor values were within 20% of the reference POC glucose with an associated average reduction in POC of 63%. Mean time in range (70–180 mg/dL) was 71.4 ± 13.9%. Sensor accuracy was impacted by mechanical interferences in four patients. CONCLUSIONS: A hybrid protocol integrating real-time CGM and POC is helpful for managing critically ill patients with COVID-19 requiring insulin infusion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc20-2085

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CGM studies in inpatients with steroid-induced hyperglycemia or posttransplant diabetes on daily steroids show that fasting glucose can be in range while hyperglycemia is mostly detected in the afternoon and evening.

    “For inpatients with steroid-induced hyperglycemia or with posttransplant diabetes receiving daily steroids, CGM studies have demonstrated that while fasting glucose could be within range, hyperglycemia is mostly detected in the afternoon and evening.1386”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1386]

    The Results (page unavailable) describe CGM use in nine critically ill patients with type 2 diabetes and COVID-19 who received steroids, but do not report fasting glucose or an afternoon–evening pattern. Searches for posttransplant diabetes and diurnal steroid-related hyperglycemia found no passage addressing the claimed pattern. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • This approach was taken to reduce PPE use and more closely monitor patients so health care personnel do not have to enter a patient room solely to measure glucose.

    “This approach has been taken to reduce the use of personal protective equipment and more closely monitor patients so that health care personnel do not have to go into a patient room solely to measure a glucose level (283-286).”

    From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [283]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 17 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Davis, G. M., Faulds, E., Walker, T., Vigliotti, D., Rabinovich, M., Hester, J., Peng, L., McLean, B., Hannon, P., Poindexter, N., Saunders, P., Perez-Guzman, C., Tekwani, S. S., Martin, G. S., Umpierrez, G., Agarwal, S., Dungan, K., & Pasquel, F. J.
Affiliations
  • Emory University (US)
  • The Ohio State University (US)
  • Grady Health System (US)
  • Morehouse School of Medicine (US)
  • Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, GA
  • Albert Einstein College of Medicine (US)
Corresponding author
Pasquel, Francisco J.
Venue
Diabetes Care
Published
2021-02-09
Volume
44
Issue
4
Pages
1055-1058
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W3126263986
Cited by
94
References
17
Citations by year
2026: 6 · 2025: 16 · 2024: 16 · 2023: 19 · 2022: 26 · 2021: 10
FWCI
13.25
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK111024)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
continuous glucose monitoring, remote glucose monitoring, COVID-19 pandemic, critically ill patients, intensive care unit, point-of-care glucose testing, sensor accuracy, mechanical ventilation, corticosteroids, time in range, diabetes management, electronic health record integration, decision support system
MeSH terms
Proof of Concept Study, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Aged, Aged, 80 and over, Algorithms, Blood Glucose, Equipment and Supplies, Female, Humans, Insulin, Insulin Infusion Systems, Intensive Care Units, Male, Middle Aged, Blood Glucose Self-Monitoring, Critical Illness, Point-of-Care Systems, Diabetes Complications, Remote Sensing Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review